A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

The companies are also running an open-label study to evaluate the long-term efficacy and safety of the psychedelic in ...

Ketamine has been making headlines for years, from the death of actor Matthew Perry to Elon Musk's reported microdosing, to its portrayal in Hulu's "The Secret Lives of Mormon Wives." ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...

"Imagine like a speck of baby powder; that's how much could be a lethal dosage of carfentanil," said Brian McNeal, public ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

Life Sciences & Beckley Psytech announce positive results from phase 2b study of BPL-003 in patients with treatment-resistant depression: New York Wednesday, July 2, 2025, 10 ...

None have been approved by the Food and Drug Administration so far, though in 2019, Johnson & Johnson received FDA permission ...

Elizabeth Haase, MD, former chair of the American Psychiatric Association's Committee on Climate Change, shared her advice ...

Michigan Department of Health and Human Services officials warned about the reemergence of a potent fentanyl alteration.